Brodeur GM - Search Results

1

Expression and function of Trk-C in favourable human neuroblastomas.

Yamashiro DJ, Liu XG, Lee CP, Nakagawara A, Ikegaki N, McGregor LM, Baylin SB, Brodeur GM. Yamashiro DJ, et al. Among authors: brodeur gm. Eur J Cancer. 1997 Oct;33(12):2054-7. doi: 10.1016/s0959-8049(97)00309-2. Eur J Cancer. 1997. PMID: 9516852 Free article.

2

Identification of a novel tyrosine kinase receptor-like molecule in neuroblastomas.

Maminta ML, Williams KL, Nakagawara A, Enger KT, Guo C, Brodeur GM, Deuel TF. Maminta ML, et al. Among authors: brodeur gm. Biochem Biophys Res Commun. 1992 Dec 15;189(2):1077-83. doi: 10.1016/0006-291x(92)92314-n. Biochem Biophys Res Commun. 1992. PMID: 1281989

3

Neuroblastoma. Effect of genetic factors on prognosis and treatment.

Brodeur GM, Azar C, Brother M, Hiemstra J, Kaufman B, Marshall H, Moley J, Nakagawara A, Saylors R, Scavarda N, et al. Brodeur GM, et al. Cancer. 1992 Sep 15;70(6 Suppl):1685-94. doi: 10.1002/1097-0142(19920915)70:4+<1685::aid-cncr2820701607>3.0.co;2-h. Cancer. 1992. PMID: 1325279

4

Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes.

Moley JF, Brother MB, Fong CT, White PS, Baylin SB, Nelkin B, Wells SA, Brodeur GM. Moley JF, et al. Among authors: brodeur gm. Cancer Res. 1992 Feb 15;52(4):770-4. Cancer Res. 1992. PMID: 1346584

5

Molecular basis of clinical heterogeneity in neuroblastoma.

Brodeur GM, Nakagawara A. Brodeur GM, et al. Am J Pediatr Hematol Oncol. 1992 May;14(2):111-6. doi: 10.1097/00043426-199205000-00004. Am J Pediatr Hematol Oncol. 1992. PMID: 1356315 Review.

6

Inverse relationship between trk expression and N-myc amplification in human neuroblastomas.

Nakagawara A, Arima M, Azar CG, Scavarda NJ, Brodeur GM. Nakagawara A, et al. Among authors: brodeur gm. Cancer Res. 1992 Mar 1;52(5):1364-8. Cancer Res. 1992. PMID: 1737399

7

Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study.

Look AT, Hayes FA, Shuster JJ, Douglass EC, Castleberry RP, Bowman LC, Smith EI, Brodeur GM. Look AT, et al. Among authors: brodeur gm. J Clin Oncol. 1991 Apr;9(4):581-91. doi: 10.1200/JCO.1991.9.4.581. J Clin Oncol. 1991. PMID: 2066755 Clinical Trial.

8

Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.

Cohn SL, Salwen H, Quasney MW, Ikegaki N, Cowan JM, Herst CV, Kennett RH, Rosen ST, DiGiuseppe JA, Brodeur GM. Cohn SL, et al. Among authors: brodeur gm. Oncogene. 1990 Dec;5(12):1821-7. Oncogene. 1990. PMID: 2284101

9

Significance of chromosome 1p loss of heterozygosity in neuroblastoma.

Maris JM, White PS, Beltinger CP, Sulman EP, Castleberry RP, Shuster JJ, Look AT, Brodeur GM. Maris JM, et al. Among authors: brodeur gm. Cancer Res. 1995 Oct 15;55(20):4664-9. Cancer Res. 1995. PMID: 7553646

10

Molecular basis for heterogeneity in human neuroblastomas.

Brodeur GM. Brodeur GM. Eur J Cancer. 1995;31A(4):505-10. doi: 10.1016/0959-8049(95)00040-p. Eur J Cancer. 1995. PMID: 7576954 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

307 results

Search Page

Filters